Chemistry & Chemical Engineering Research Center of Iran (CCERCI), P.O. Box 14335-186, Tehran, Iran
Research Article
Boron Neutron Capture Therapy of Mcf-7 Breast Cancer Cells by Using Calcium Fructoborate@Au Nanoparticles Drug Encapsulated in Liposomal Nanocarriers: In-vitro Experimental Investigation
Author(s): Meisam Sadeghi*, Zahra Moghimifar and Hamedreza Javadian
In this research, calcium fructoborate (CFB) complex containing enriched 10B was used as a drug. The liposome prepared from phosphatidylcholine
was applied as a biological macromolecule carrier of the drug. The liposome-encapsulated CFB (LECFB) was applied to treat MCF-7 breast cancer
cells. The study demonstrated that AuNPs added to LECFB in the core-shell structure of LECFB with AuNPs (LECFB@AuNPs) can be considered
selectively for the specific biological labeling and delivery of large quantities of boron to the cancer cells, respectively. Polyethylene glycol (PEG)
and folic acid (FA) were chosen as appropriate substrates to potentially attach to folate receptors (FR) on the surface of cancer cells before
liposomal formulation. The size of folate-conjugated LECFB@AuNPs was around 240.9 nm, while the size of synthesized LECFB was 142.3
nm. The optimum encapsul.. Read More»
DOI:
10.37421/2155-9619.2022.13.496
Nuclear Medicine & Radiation Therapy received 706 citations as per Google Scholar report